The Diaphanous-related formin Dia1 nucleates actin polymerization, thereby regulating cell shape and motility. Mechanisms that control the cellular location of Dia1 to spatially define actin polymerization are largely unknown. In this study, we identify the cytoskeletal scaffold protein IQGAP1 as a Dia1-binding protein that is necessary for its subcellular location. IQGAP1 interacts with Dia1 through a region within the Diaphanous inhibitory domain after the RhoA-mediated release of Dia1 autoinhibition. Both proteins colocalize at the front of migrating cells but also at the actin-rich phagocytic cup in macrophages. We show that IQGAP1 interaction with Dia1 is required for phagocytosis and phagocytic cup formation. Thus, we identify IQGAP1 as a novel component involved in the regulation of phagocytosis by mediating the localization of the actin filament nucleator Dia1.

The RhoA-effector Dia1 controls actin-dependent processes such as cytokinesis, SRF transcriptional activity, and cell motility. Dia1 polymerizes actin through its formin homology (FH) 2 domain. Here we show that Dia1 acts upstream of RhoA independently of its effects on actin assembly. Dia1 binds to the leukemia-associated Rho-GEF (LARG) through RhoA-dependent release of Dia1 autoinhibition. The FH2 domain stimulates the guanine nucleotide exchange activity of LARG in vitro. Our results reveal that Dia1 is necessary for LPA-stimulated Rho/ROCK signaling and bleb-associated cancer cell invasion. Thus, Dia1-dependent RhoA activation constitutes a positive feedback mechanism to modulate cell behavior.Supplemental material is available at http://www.genesdev.org.Received January 11, 2007; revised version accepted May 8, 2007. Diaphanous-related formins (DRFs) are Rho-GTPasebinding proteins that possess conserved functions in actin cytoskeleton dynamics exerted through their formin homology (FH) 2 domains (Goode and Eck 2007). DRFs are involved in essential cellular processes such as cytokinesis, cell movement, and polarity (Faix and Grosse 2006;Gomez et al. 2007), which are frequently deregulated during pathological situations like tumor cell transformation and metastasis (Sahai 2005). The dormant conformation of the DRF Dia1 is maintained by intramolecular association of its regulatory N terminus to the diaphanous autoregulatory domain (DAD), which is relieved through binding of active RhoA (Lammers et al. 2005;Otomo et al. 2005a). The catalytic FH2 domain is believed to become "exposed" by conformational changes in the DRFs to promote barbed end actin polymerization by forming a tethered dimer (Xu et al. 2004;Otomo et al. 2005a). The FH2 domain of Dia1 promotes stress fiber formation and transcriptional activation of the MAL/SRF pathway through its actin-polymerizing activity (Copeland and Treisman 2002;Grosse et al. 2003;Miralles et al. 2003). A Dia1 mutant defective in FH2 dimerization interferes with lysophosphatidic acid (LPA)-induced stress fiber formation and SRF activity (Copeland and Treisman 2002), suggesting that Dia1 is part of LPA signal transduction known to play an important role in cell proliferation and metastasis of a variety of human cancers (Mills and Moolenaar 2003). LPA receptors belong to the group of G-protein-coupled receptors that activate the heterotrimeric G-proteins G 12 and G 13 , which can bind to RGS-containing Rho-GEFs such as leukemia-associated Rho-GEF (LARG), initially isolated from a patient with acute myeloid leukemia (AML) (Kourlas et al. 2000;Vazquez-Prado et al. 2004). Rhodependent mechanisms have emerged as critical processes in tumor progression (Sahai and Marshall 2002;Lozano et al. 2003), and evidence exists that Rho/ROCK function is essential to promote a specific type of rounded bleb-associated mode of cell invasion (Sahai and Marshall 2003;Wyckoff et al. 2006). However, the role of DRFs in tumor cell behavior has not been investigated.In this study, we provide evi...

We have investigated the mechanism of PKC-induced actin reorganization in A7r5 vascular smooth muscle cells. PKC activation by 12-O-tetradecanoylphorbol-13-acetate induces the disassembly of actin stress fibers concomitant with the appearance of membrane ruffles. PKC also induces rapid tyrosine phosphorylation in these cells. As we could show, utilizing the Src-specific inhibitor PP2 and a kinase-deficient c-Src mutant, actin reorganization is dependent on PKC-induced Src activation. Subsequently, the activity of the small G-protein RhoA is decreased, whereas Rac and Cdc42 activities remain unchanged. Disassembly of actin stress fibers could also be observed using the Rho kinase-specific inhibitor Y-27632, indicating that the decrease in RhoA activity on its own is responsible for actin reorganization. In addition, we show that tyrosine phosphorylation of p190RhoGAP is increased upon 12-O-tetradecanoylphorbol-13-acetate stimulation, directly linking Src activation to a decrease in RhoA activity. Our data provide substantial evidence for a model elucidating the molecular mechanisms of PKC-induced actin rearrangements.The living cell has a dynamic actin cytoskeleton. To provide cell motility and adhesion and to allow cell division, the cell needs a tightly regulated and highly coordinated system of actin polymerization and depolymerization. The Rho (Ras homology) family of small GTP-binding proteins plays a central role in regulating the dynamic modulation of the actin cytoskeleton; the activity of Rho is thought to be responsible for the assembly of actin stress fibers and focal adhesions, whereas Rac is thought to be involved in the generation of lamellipodia and focal complexes, and Cdc42 is thought to be involved in microspike formation (reviewed in Refs.

Gene expression reprogramming governs cellular processes such as proliferation, differentiation and cell migration through the complex and tightly regulated control of transcriptional cofactors that exist in multiprotein complexes. Here we describe SCAI (suppressor of cancer cell invasion), a novel and highly conserved protein that regulates invasive cell migration through three-dimensional matrices. SCAI acts on the RhoA-Dia1 signal transduction pathway and localizes in the nucleus, where it binds and inhibits the myocardin-related transcription factor MAL by forming a ternary complex with serum response factor (SRF). Genome-wide expression analysis surprisingly reveals that one of the strongest upregulated genes after suppression of SCAI is beta1-integrin. Decreased levels of SCAI are tightly correlated with increased invasive cell migration, and SCAI is downregulated in several human tumours. Functional analysis of the beta1-integrin gene strongly argues that SCAI is a novel transcriptional cofactor that controls gene expression downstream of Dia1 to dictate changes in cell invasive behaviour.